Dr. Gregory Bell was appointed Monitor by the FTC in several healthcare transactions to monitor Respondents’ compliance with post-merger divestiture obligations and other related requirements of the agreement. Dr. Bell and the CRA team complied with all monitor obligations, including conducting weekly and bi-weekly calls with the respective parties, and submitting a monthly report to the FTC on activities, issues, and opinions related to the divestiture obligations.
Removing the roadblocks: Policies to improve access to long-acting reversible contraceptives (LARCs)
A variety of contraceptive options exist, each with their own pros and cons. Long-acting reversible contraceptives (LARCs), like IUDs, contraceptive...